In this follow-up feature, we review some of the developments since that initial recall ... in February 2020, the FDA said initial lab analyses of certain domestic metformin products did in ...

Marksans Pharma Limited has now issued an expanded recall for its Metformin Hydrochloride extended-release tablets because they may contain N-Nitrosodimethylamine (NDMA) – a possible cancer ...

Several drug manufacturers issued recalls for the diabetes ... 2018, to May 22, 2020. Earlier in June, Lupin also recalled Metformin Hydrochloride Extended-Release tablets sold in 500 mg dosages ...

An existing recall of popular diabetes medication metformin has been expanded over the presence of an impurity that may increase cancer risk. The expanded recall comes from Marksans Pharma Ltd ...

Nostrum Laboratories Inc., based in Kansas City, Missouri, announced Monday that it is voluntarily recalling its metformin HCl extended release tablets, USP 750 mg, according to a recall posted by ...

Marksans Pharma Limited of India has expanded a recall it issued ... expiration dates are: 1. Metformin HCL ER Tablets, USP 500 mg, 49483-623-50, 500E037F, October 2020 2. Metformin HCL ER Tablets ...

As a result, the agency contacted five manufacturing firms to recommend a voluntary recall of the ... levels of NDMA in metformin products sold in the U.S. in February 2020. But because no samples ...

The recall applies to metformin tablets between 500 mg and 750 mg. The 500 mg tablets are debossed with “101” on one side; the 750 mg tablets are debossed with “102” on one side ...

Metformin tablets are used to treat type 2 diabetes and are designed to lower glucose levels. The recall applies to metformin tablets between 500 mg and 750 mg, sold under the brand name Time-Cap ...

The FDA recommends that people prescribed metformin should continue taking it until their doctor prescribes an alternative. A voluntary recall of Metformin ... that through 2020 and early 2021 ...

Metformin tablets are used to decrease glucose levels and treat type 2 diabetes. The recall applies to metformin tablets ranging between 500 milligrams and 750 milligrams, which are sold under the ...